Skip to content

Intraoperative Pain Management for Treatment-Resistant Complex Regional Pain Syndrome: A Case Report.

Catherine R La Spina, Patricia Pozo, Gisele J Wakim

Cureus November 1, 2024 DOI: 10.7759/cureus.72935 via PubMed

Summary

AI-generated from the abstract

Complex regional pain syndrome (CRPS) is a chronic pain disorder that often follows trauma, causing severe pain and autonomic disturbances. Managing CRPS is difficult because no FDA-approved medications exist, and off-label treatments like NSAIDs, corticosteroids, gabapentin, antidepressants, and bisphosphonates have limited or varying efficacy. Surgical options such as nerve blocks and spinal cord stimulation can help but have inconsistent success. A case study describes a patient with a treatment-resistant CRPS flare-up managed through revision neurolysis of the sciatic, tibial, and perineal nerves, release of the right tibial nerve, and intraoperative ketamine.

Study at a glance

Characteristics Case study Case report Peer reviewed
Sample size 1
Population A patient with treatment-resistant complex regional pain syndrome
Interventions revision neurolysis of the sciatic tibial and perineal nerves release of the right tibial nerve intraoperative ketamine
Keywords Chronic neuropathic pain Crps pathophysiology Intraoperative ketamine Stages of crps Pain-management
Key finding A patient with treatment-resistant CRPS achieved remission after nerve decompression, but symptoms returned severely following a subsequent trauma, and intraoperative ketamine provided rapid pain relief during and after surgery.

Abstract

Complex regional pain syndrome (CRPS) is a chronic neuropathic pain disorder often following trauma, associated with severe pain and autonomic disturbances in the affected limbs. Managing CRPS is challenging due to the lack of FDA-approved medications, often requiring off-label treatments. Traditional options like nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids show limited efficacy, while adjunctive treatments such as gabapentin, antidepressants, and bisphosphonates are increasingly favored. Surgical interventions, including nerve blocks and spinal cord stimulation, may help in refractory cases but have varying success rates. Recent discussions highlight intraoperative ketamine, which targets N-methyl-D-aspartate (NMDA) pathways linked to CRPS. This case study illustrates the complexity of CRPS management, particularly how psychosocial factors and secondary trauma can exacerbate or alleviate symptoms. The case centers on a treatment-resistant flare-up of CRPS, managed through revision neurolysis of the sciatic, tibial, and perineal nerves, along with the release of the right tibial nerve and intraoperative ketamine. Trauma's impact is evident, as the patient initially went into remission after nerve decompression, only for symptoms to return severely following a subsequent trauma. This emphasizes the need for a multipronged treatment approach. Intraoperative ketamine provides rapid pain relief during and after surgery, benefiting patients with severe chronic pain while reducing post-surgery opioid needs and minimizing dependency risks. Patients typically achieve improved functional recovery and better rehabilitation engagement. Research suggests ketamine may offer long-lasting pain relief and psychological benefits, positively impacting mood and anxiety.

Comments

No comments yet.

Log in to comment